How can the development of brain stem cells into neurons cause cancer?

| February 1, 2019

article image
Scientists have identified how brain stem cells could cause brain cancer instead of developing into neurons. Researchers at the German Cancer Research Center (DKFZ) followed stem cells along the path of development towards becoming neurons. The team analyzed each step where genes were switched on and which of them actually transferred into new proteins.

Spotlight

PANTAI HOLDINGS BERHAD

Pantai Group is anchored by more than 890 doctors and 2,800 nurses in Malaysia, delivering quality, service and value through a full spectrum of integrated healthcare services and a wide range of ancillary services including laboratory and rehabilitation. Leveraging on a strong track record of managing world-class hospitals, the Pantai Group continues to make a difference in people’s lives through excellent patient care, while steadily expanding its reach in markets where demand for quality care is strong and growing.

OTHER ARTICLES

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

3 Big Pharma Stocks Plunging the Most During the Coronavirus Stock Market Crash: Are They Buys?

Article | March 26, 2020

Big pharma stocks have been clobbered during the coronavirus-caused stock market crash. You can count the number of drugmakers with market caps of $25 billion or more whose shares haven't dropped by double-digit percentages on one hand -- and have several fingers left over. Three big pharma stocks have plunged the most: AbbVie (NYSE:ABBV), Bristol Myers Squibb (NYSE:BMY), and Pfizer (NYSE:PFE). But are these stocks smart picks to buy right now?

Read More

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Spotlight

PANTAI HOLDINGS BERHAD

Pantai Group is anchored by more than 890 doctors and 2,800 nurses in Malaysia, delivering quality, service and value through a full spectrum of integrated healthcare services and a wide range of ancillary services including laboratory and rehabilitation. Leveraging on a strong track record of managing world-class hospitals, the Pantai Group continues to make a difference in people’s lives through excellent patient care, while steadily expanding its reach in markets where demand for quality care is strong and growing.

Events